Clinical trial · Observational
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
NCT05548621CI-TRIAL-00089756SDM-RCCrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
| Renal Cell Carcinoma Metastatic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Decision aid | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Pre-test
- description
- Patients with RCC receiving usual care (without use of the decision aids)
- label
- Post-test
- description
- Patients with RCC using the decision aids
- interventionNames
- Other: Decision aid
Primary outcomes (1)
- measure
- OPTION-5
- timeFrame
- During consultation
- description
- Observed patient involvement in decision-making
Secondary outcomes (6)
- measure
- Decisional conflict scale
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients clinically diagnosed with RCC * Patients facing a decision which is addressed in the decision aids (T1 tumor or metastatic disease) * Written informed consent Exclusion Criteria: * Patients who are not able to fill in a questionnaire or undergo an interview individually
References
Publications (0)
Data not yet available
No reference posted for this study.